Ortho Dermatologics Submits New Drug Application To The U.S...
5, 2017 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administrati...